Biomerica expands CDMO services to meet growing market demand

Biomerica (BMRA) announced the expansion of its Contract Development and Manufacturing Organization, CDMO, services to meet accelerating market demand. The Company is enhancing its capabilities to provide greater value and reliability of product development and manufacturing across the entire development lifecycle for diagnostic innovators worldwide. “Over the past several years, we have experienced a meaningful increase in interest from both large diagnostic organizations to smaller innovative organizations who are seeking to leverage our specialized development expertise, regulatory compliance track record, and manufacturing capabilities,” said Zack Irani, CEO of Biomerica. “We are now formalizing and expanding these CDMO services, providing clients with end-to-end support from concept through commercial manufacturing.”